Patents Examined by S. L.
  • Patent number: 11970226
    Abstract: An elastic crawler capable of effectively preventing an occurrence of vibration, noise and cracks during driving while improving durability is provided. The elastic crawler includes a coupling portion arranged at equal intervals in a circumferential direction at a center in a left and right direction of a crawler body, a steel core arranged in the left and right direction between adjacent coupling portions in the circumferential direction of the crawler body, and two rows of left and right lugs installed on an outer periphery of the crawler body, wherein each of the rows of the lugs includes driving lugs arranged in an oblique direction with respect to the steel core, and each of the driving lugs overlaps with two adjacent steel cores in the circumferential direction.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: April 30, 2024
    Inventor: Yong Jae Choi
  • Patent number: 11932049
    Abstract: Assembly of a rim and of a flexible adapter, intended to make up, with a tyre, a rolling assembly. The rim having a mounting well that is extended axially by a boss, a rim seat and a rim flange that extends the rim seat axially on the outside, with a bearing face of substantially radial orientation. The adapter having an axially inner end intended to rest on the rim seat, an axially outer end and a substantially cylindrical body that connects the axially inner end and the axially outer end and is intended to receive, in cooperation with the axially outer end, a tyre bead. The rim seat of the rim has an inclination relative to the axis of rotation of between ?2 and +6 degrees, the angle being counted as positive when the virtual vertex of the substantially frustoconical seat is situated axially on the outside.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: March 19, 2024
    Assignee: MAXION WHEELS HOLDING GMBH
    Inventors: Daniel Walser, Johan Vits, Bertrand Vedy
  • Patent number: 11919585
    Abstract: A track tension system including a hydraulic cylinder coupled between a drive frame and idler of a track system, an accumulator and a hydraulic valve that controls flow between the cylinder and accumulator. The cylinder extends and retracts to change the distance between the drive frame and idler which increases and decreases, respectively, tension on the track system. The hydraulic valve can be opened to allow flow between the cylinder and accumulator, and closed to block flow between the cylinder and accumulator. Control factors can be monitored to control valve position. An overload pressure relief can allow flow between the cylinder and accumulator when the hydraulic valve is closed and pressure in the cylinder reaches overload pressure. An orifice can allow constricted flow between the cylinder and accumulator when the hydraulic valve is closed. A check valve can connect the track tension system to a vehicle hydraulic system.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: March 5, 2024
    Assignee: DEERE & COMPANY
    Inventors: Bruce S. Johnson, Dennis A. Bowman, Benjamin J. Heimbuch, Daniel J. Garvin, Randall K. Bill, Jeremy P. L'Heureux
  • Patent number: 11912355
    Abstract: An endless track vehicle with increased traction and/or installation, modification, and/or use of track cleats for traction for the endless track of the endless track vehicle. A body is mountable to the endless track exterior. The body defines bores extending from a first end of the body to a second end of the body, wherein the bores have counterbores. First and second cleats/bolts respectively having a cleat/bolt heads, the cleats/bolts mounted in respective bores and optional extending out a distance out of the second end of the body, wherein the cleat/bolt heads seat in the respective counterbores. Nuts may be used in the counterbores to optionally extend the cleats/bolts, and/or to secure and fasten the cleats/bolts.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: February 27, 2024
    Assignee: Quanta Associates, L.P.
    Inventor: Daniel Robert Berube
  • Patent number: 9237107
    Abstract: Technologies are generally described for an enhanced Quantized Congestion Notification (QCN) congestion control approach, referred to as Fair QCN (FQCN) for enhancing fairness of multiple flows sharing link capacity in a high bandwidth, low latency data center network. QCN messages may be fed back to flow sources (e.g., servers) which send packets with a sending rate over their share of the bottleneck link capacity. By enabling the flow sources to regulate their data traffic based on the QCN messages from a congestion control component, the queue length at the bottleneck link may converge to an equilibrium queue length rapidly and TCP throughput performance may be enhanced substantially in a TCP incast circumstance.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: January 12, 2016
    Assignee: NEW JERSEY INSTITUTE OF TECHNOLOGY
    Inventors: Nirwan Ansari, Yan Zhang
  • Patent number: 6698626
    Abstract: A lint remover and spray dispenser apparatus rotatably supports a tubular adhesive lint remover tape roll or fixedly supports a single strip or multiple strips of a directional lint remover fabric. The apparatus includes an elongated handle section and a cylindrical or oblong support section. The elongated handle has an open end having external threads adjacent to the open end. A spray top having a hand pump and a threaded cap is mounted on the elongated handle. The liquid container-handle combination may be a molded polymer container having a trigger activated spray pump attached thereto. Alternately, the handle is configured to receive a separate liquid spray dispenser container.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: March 2, 2004
    Inventor: William D. McKay
  • Patent number: 6659310
    Abstract: A product dispensing and drainback fitting, for directing the flow of a liquid product from a container and minimizing the occurrence of double pour, having an outer wall for engagement with the neck of said container; an inner spout centrically positioned within said outer wall, a base extending between said wall and said spout and creating a circumscribing well, a longitudinal slot formed in said inner spout, said longitudinal slot beginning at a point about 30 mm to about 48 mm above said base and extending the remainder of the length of said spout; and drainback hole formed in said base and aligned with said longitudinal slot, said drainback hole having an area of about 10 mm2 to about 20 mm2.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: December 9, 2003
    Assignee: The Dial Corporation
    Inventor: Christopher J. Wolpert
  • Patent number: 6207648
    Abstract: Methods of killing neoplastic cells are provided. The invention relates to the use of NADPH-cytochrome P450 reductase (RED) gene transfer in combination with cytochrome P450 gene transfer to enhance the sensitivity of tumor cells to anti-cancer drugs that are activated by P450 enzymes. The use of bioreductive drugs that are activated by RED and/or cytochrome P450, in this paradigm, is also provided.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: March 27, 2001
    Assignee: Trustees of Boston University
    Inventors: David J. Waxman, Ling Chen
  • Patent number: 6177540
    Abstract: This invention relates to pressure sensitive adhesives, and processes of preparing such adhesives, comprising random star polymers which are crosslinked by reaction with multifunctional crosslinking agent. These adhesives can be used in coated articles.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: January 23, 2001
    Assignee: National Starch and Chemical Investment Holding Corporation
    Inventors: Robert D. Harlan, Jules E. Schoenberg, Christopher G. Gore, Deepak Hariharan, Smita M. Shah
  • Patent number: 5256643
    Abstract: A new human gene designated as "CRIPTO" gene has been identified and cloned. CRIPTO gene products and derivatives thereof have been obtained and various utilities of the same have been described. Association of CRIPTO gene with cancers, such as colorectal cancer and breast carcinoma, has been indicated.
    Type: Grant
    Filed: May 29, 1990
    Date of Patent: October 26, 1993
    Assignee: The Government of the United States
    Inventors: Maria G. Persico, David S. Salomon
  • Patent number: 5238916
    Abstract: This invention provides a purified polypeptide having growth factor activity and a defined amino acid sequence. The invention also provides a purified nucleic acid molecule encoding the polypeptide. This invention further provides methods for producing the polypeptide as well as uses thereof. Finally, this invention provides methods for detecting the polypeptide.
    Type: Grant
    Filed: May 27, 1988
    Date of Patent: August 24, 1993
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Mitchell Goldfarb, Xi Zhan
  • Patent number: 5208631
    Abstract: A technique to identify colorimetric properties of toner contained within a cartridge in a reproduction machine by embedding in a PROM within the cartridge specific coordinates of a color coordinate system and entering the color coordinate information into the data base of the machine to accurately map color data from one color domain such as a full color domain to another color domain such as a highlight color domain.
    Type: Grant
    Filed: December 9, 1991
    Date of Patent: May 4, 1993
    Assignee: Xerox Corporation
    Inventors: Timothy W. Jacobs, David M. Korvick
  • Patent number: 5200327
    Abstract: A gene expression system is used to produce heterologous biologically active proteins, in particular bioactive granulocyte macrophage colony stimulating factor ("GM-CSF"), secreted from a host selected from the Streptomyces genera. The gene expression system includes a regulatory nucleotide sequence linked to a second nucleotide sequence encoding the heterologous protein. The regulatory sequence, encodes a peptide which directs the secretion of the heterologous protein in bioactive form from a host selected from the Streptomyces genera. The regulatory sequence includes a signal sequence and a promoter sequence. The second nucleotide sequence, which encodes GM-CSF or a biologically active derivative of GM-CSF, may be either natural or synthetic. In particular, the invention relates to an expression system for secreting bioactive, non-glycosylated, oxidized, therapeutically useful GM-CSF from a host selected from the Streptomyces genera.
    Type: Grant
    Filed: July 26, 1988
    Date of Patent: April 6, 1993
    Assignee: Cangene Corporation
    Inventors: Robert T. Garvin, Lawrence T. Malek
  • Patent number: 5196335
    Abstract: A double-stranded cDNA molecule which includes DNA encoding human cytoplasmic superoxide dismutase has been created. The sequence of one strand of a double-stranded DNA molecule which encodes human cytoplasmic superoxide dismutase has been discovered. Such molecules may be introduced in procaryotic, e.g., bacterial, or eucaryotic, e.g., yeast or mammalian, cells and the resulting cells cultured or grown under suitable conditions so as to produce human cytoplasmic superoxide dismutase which may then be recovered.
    Type: Grant
    Filed: July 2, 1990
    Date of Patent: March 23, 1993
    Assignee: Yeda Research and Development Co., Ltd.
    Inventor: Yoram Groner
  • Patent number: 5194376
    Abstract: A baculovirus expression system capable of producing foreign gene proteins at high levels. The system involves the production of a recombinant baculovirus containing a modified foreign gene between the polyhedrin gene promoter region and the transcription termination signal of the polyhedrin structural gene. The modified foreign gene comprises a putative ribosome binding site immediately upstream of the foreign gene coding sequence, i.e. without any intervening non-coding sequences. The putative ribosome binding site is preferably properly positioned without the intervening sequences by a crossover linker mutagenesis procedure before the modified foreign gene is introduced into the virus. The putative ribosome binding site preferably comprises at least the final four nucleotides of the sequences ACCTATAAAT immediately upstream of the translation inibiation codon (ATG) of the foreign gene.
    Type: Grant
    Filed: February 28, 1989
    Date of Patent: March 16, 1993
    Assignee: University of Ottawa
    Inventor: C. Yong Kang
  • Patent number: 5182196
    Abstract: Recombinant DNA molecules comprising DNA sequences derived from bacteriophage T4 that are useful in expressing desired polypeptides in unexpectedly high yields, hosts and expression systems comprising such recombinant DNA molecules and methods for expressing desired polypeptides in high yields by the utilization of such hosts and expression systems.
    Type: Grant
    Filed: June 27, 1989
    Date of Patent: January 26, 1993
    Assignee: Biogen, Inc.
    Inventors: Bernard Allet, Eric H. Kawashima
  • Patent number: 5171677
    Abstract: A recombinant Marek's disease virus which comprises a Marek's disease virus genom and a DNA fragment incorporated therein, said DNA fragment being constructed by incorporating a promoter derived from an animal cell or an animal virus and a structural gene coding for an exogenous protein into a gene fragment derived from a Marek's disease virus, a process for preparing the same which comprises preparing a gene fragment wherein a structural gene coding for an exogenous gene is linked to the downstream of a promoter derived from an animal cell or an animal virus, incorporating said gene fragment into a BamHI - H fragment of a gene of a Marek's disease virus type I, and incorporating said fragment into a Marek's disease virus type I genome, and a multivalent live vaccine for birds comprising the same.
    Type: Grant
    Filed: September 8, 1989
    Date of Patent: December 15, 1992
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Masashi Sakaguchi, Hiroaki Maeda, Michitaka Yamamoto, Junichi Miyazaki
  • Patent number: 5169784
    Abstract: This invention relates to specifically designing and genetically engineering recombinant baculovirus for producing, in a compatible insect system, a desired protein, virus, protein hybrid, or virus hybrid. In particular aspects, this invention relates to the use of different baculovirus promoters for the ultimate purpose of constructing a recombinant baculovirus designed for the investigator's specific need. For example, the recombinant baculovirus of this invention can be designed to produce a viral pesticide.This invention also describes the construction of a genetically engineered virus or virus hybrid (e.g. animal or human pathogen) which is not capable of replicating itself but is essentially identical to the authentic pathogen in terms of structure and antigenicity.
    Type: Grant
    Filed: September 17, 1990
    Date of Patent: December 8, 1992
    Assignee: The Texas A & M University System
    Inventors: Max D. Summers, Christian E. G. Oker-Blom
  • Patent number: 5162217
    Abstract: An improved plasmid for the production of superoxide dismutase which upon introduction into a host containing the thermolabile repressor C.sub.I renders the host capable of effecting expression of a gene encoding superoxide dismutase. The plasmid which includes in 5' to 3' order the following: the promoter and operator P.sub.L O.sub.L from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal binding site; an ATG initiation codon; a second restriction enzyme site; a gene encoding superoxide dismutase; an origin of replication and a gene associated with a selectable or identifiable phenotypic trait manifested when the plasmid is present in the host. The distance between the 3' end of P.sub.L O.sub.L and the 5' end of the N utilization site is less than about 80 base pairs.
    Type: Grant
    Filed: December 8, 1989
    Date of Patent: November 10, 1992
    Assignee: Bio-Technology General Corp.
    Inventors: Jacob R. Hartman, Amos B. Oppenheim, Marian Gorecki, Haim Aviv, Rachel Oren
  • Patent number: 5159068
    Abstract: A DNA sequence, characterized by coding the main subunits of the ATP synthase from methanogenic bacteria.
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: October 27, 1992
    Assignee: Mitsubishi Denki Kabushiki Kaisha
    Inventors: Kenichi Inatomi, Masamitsu Futai